Last reviewed: July 11, 2026
Last updated: July 11, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide, the active ingredient in Mounjaro, degrades over time when exposed to improper temperatures or after its expiration date has passed. Using expired GLP-1 medication not only reduces its ability to regulate appetite and blood sugar, but it also carries potential health risks that patients often overlook.
What Happens When Tirzepatide Expires
Tirzepatide is a peptide-based medication composed of amino acids and molecular structures that break down under specific conditions. Once a vial or pen reaches its expiration date, the chemical bonds holding the compound together begin to degrade, reducing its therapeutic effectiveness. Expired tirzepatide may no longer suppress appetite hormones as intended, meaning injections become ineffective at supporting weight loss goals.
Beyond loss of potency, expired medications stored in non-sterile conditions can develop bacterial contamination. Bacteria may colonize the medication vial if the rubber septum has been punctured multiple times or if the injection pen has been left at room temperature for extended periods. This contamination risk makes expired tirzepatide not just ineffective—but potentially harmful when injected into the body.
Proper Storage Guidelines for Tirzepatide Injections
Tirzepatide pens and vials must be stored in a refrigerator between 36°F and 46°F (2°C to 8°C) before first use. Once you begin using a tirzepatide pen, it can remain at room temperature (below 86°F or 30°C) for up to 28 days, after which it should be discarded. Never freeze tirzepatide, as freezing temperatures permanently damage the peptide structure and render the medication unusable.
If you travel, keep tirzepatide in a portable cooling pouch with ice packs or a battery-operated cooler to maintain proper temperature ranges. After each injection, replace the needle cap and return the pen to refrigeration if you won't use it within 28 days. Check your vial or pen's expiration date monthly, and never use medication that has passed the printed date, even if it appears clear and colorless.
Health Risks Associated with Using Expired Tirzepatide
The primary risk of expired tirzepatide is treatment failure—patients inject a medication that no longer activates GLP-1 and GIP receptors in the brain, which are responsible for appetite suppression and weight loss. When peptide chains degrade, they lose their ability to bind to these receptors, meaning you receive no therapeutic benefit while paying for treatment. This can delay weight loss progress and frustrate patients on their health journeys.
Secondary risks include immune reactions to degraded peptide fragments and potential infections from bacterial contamination. Some patients report injection site reactions, fever, or systemic symptoms after using expired or improperly stored tirzepatide, suggesting immune activation against foreign particles. Additionally, using ineffective medication may lead patients to increase injection frequency incorrectly, thinking they need higher doses when the real problem is medication degradation.
How PlexusDx Ensures Fresh, Effective Tirzepatide Delivery
PlexusDx sources compounded tirzepatide from licensed 503A compounding pharmacies that follow FDA USP (United States Pharmacopeia) standards for sterility, potency, and stability. Each medication batch is prepared on-demand based on your personalized treatment plan, ensuring you receive the freshest possible injectable tirzepatide. PlexusDx ships tirzepatide with temperature-controlled packaging and insulated containers to maintain the cold chain from pharmacy to your door.
PlexusDx compounded tirzepatide injection starts at $289/mo (or $249/mo on the 6-month plan), with your dose able to increase as needed—but your price remains flat. This predictable pricing model removes financial barriers to consistent, effective weight loss treatment. Patients also receive detailed storage instructions, refill reminders, and access to the Precision Peptide Genetic Test ($99 add-on after first month) to identify genetic variants affecting GLP-1 and GIP pathway sensitivity, enabling truly personalized therapy.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I use Mounjaro after its expiration date if it still looks clear?
No. Visual clarity does not indicate potency or sterility. Tirzepatide may appear unchanged while its peptide structure degrades and bacteria colonize the vial. Always discard tirzepatide on or after its printed expiration date, regardless of appearance.
How long is tirzepatide effective after the expiration date passes?
Tirzepatide should never be used after expiration. Degradation accelerates beyond the expiration date, and potency loss is unpredictable. Using expired medication wastes money and delays weight loss progress, making it essential to follow expiration dates strictly.
What is the difference between PlexusDx compounded tirzepatide and brand-name Mounjaro?
PlexusDx tirzepatide comes from licensed 503A compounding pharmacies and is prepared to your specific needs at $289/month flat pricing with no dose-based increases. Compounded tirzepatide provides the same active ingredient as Mounjaro but with affordability, no insurance requirement, and HSA/FSA eligibility.
What should I do if my tirzepatide pen was left out of the refrigerator overnight?
If tirzepatide was left at room temperature for fewer than 28 days from first use, it is still safe to use if stored properly going forward. However, if left unrefrigerated before first use or for extended periods, contact your pharmacy to determine safety. When in doubt, discard and request a replacement to avoid reduced effectiveness.
How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R (rs6923761), and GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How to Travel with Mounjaro: Your Guide to Safe and Stress-Free Medication Travel
How to Use Weight Loss Injections: Mounjaro Explained